Published in Q J Med on May 01, 1994
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut (1997) 1.13
Testing to check success of treatment to eradicate H pylori. Routine retesting is necessary. BMJ (1996) 0.89
Testing to check success of treatment to eradicate H pylori. Patients' wellbeing should not be risked for marginal cost savings. BMJ (1996) 0.88
Testing to check success of treatment to eradicate H pylori. BMJ (1996) 0.75
The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail. J Urban Health (1998) 0.75
Upper gastrointestinal endoscopy. BMJ (1995) 0.75
PRINTS and its automatic supplement, prePRINTS. Nucleic Acids Res (2003) 10.01
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut (1995) 4.70
Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry (2000) 4.44
Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ (2001) 3.81
Amelogenin-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem (2001) 3.50
Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut (1991) 3.14
A complex of nuclear pore proteins required for pore function. J Cell Biol (1991) 2.87
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol (2001) 2.67
Prevention of hypoxaemia during upper-gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet (1987) 2.60
Gallstone dissolution in man using chenodeoxycholic acid. Lancet (1972) 2.55
The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev (2011) 2.37
Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper gastrointestinal endoscopy. Br J Clin Pharmacol (1987) 2.36
Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design. Endoscopy (1999) 2.23
Towards automated cellular image segmentation for RNAi genome-wide screening. Med Image Comput Comput Assist Interv (2005) 2.19
Supervision registers for mentally ill people. BMJ (1994) 2.14
Defining morning stiffness in rheumatoid arthritis. J Rheumatol (1999) 2.12
Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry (1999) 2.09
Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br Med J (1980) 2.09
Care-seeking for fatal illnesses in young children in Indramayu, west Java, Indonesia. Lancet (1993) 2.02
Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol (1984) 1.99
Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther (1992) 1.99
Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. N Engl J Med (1975) 1.97
Patterns and predictors of hospitalisation in first-episode psychosis. Prospective cohort study. Br J Psychiatry (2001) 1.87
Simple half-gram stain for showing presence of Campylobacter pyloridis in sections. J Clin Pathol (1987) 1.84
The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand (2006) 1.76
Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med (1993) 1.74
Factors influencing human gallstone dissolution in monkey, dog, and human bile. Gut (1972) 1.73
Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol (1997) 1.72
Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study. Br J Psychiatry (2005) 1.70
Matrix metalloproteinase-1 and skin ageing in smokers. Lancet (2001) 1.69
Prospective evaluation of the McMurray test. Am J Sports Med (1993) 1.64
Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (1995) 1.61
Is food insufficiency associated with health status and health care utilization among adults with diabetes? J Gen Intern Med (2001) 1.61
Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry (1995) 1.60
The Ty1-copia group retrotransposons in Vicia species: copy number, sequence heterogeneity and chromosomal localisation. Mol Gen Genet (1996) 1.59
A modified fascia iliaca compartment block has significant morphine-sparing effect after total hip arthroplasty. Anaesth Intensive Care (2007) 1.58
The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut (1975) 1.58
Anti-Helicobacter pylori therapy: clearance, elimination, or eradication? Lancet (1991) 1.57
Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56
Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.54
Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers. J Clin Invest (1982) 1.54
Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg (1995) 1.53
Colonoscopy--is sedation necessary and is there any role for intravenous propofol? Endoscopy (2000) 1.51
Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med (2000) 1.48
Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency. Clin Exp Immunol (1984) 1.48
Systematic assessments of need and care planning in severe mental illness: cluster randomised controlled trial. Br J Psychiatry (2004) 1.47
Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence. Rheumatology (Oxford) (2008) 1.46
Outcome of endoscopy and barium radiography for acute upper gastrointestinal bleeding: controlled trial in 1037 patients. Br Med J (Clin Res Ed) (1982) 1.46
Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones. Lancet (1974) 1.44
Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol (1996) 1.44
Premorbid personality in first-onset psychosis. Br J Psychiatry (1994) 1.42
The present position concerning gallstone dissolution. Gut (1974) 1.41
Post-traumatic stress disorder. Br J Psychiatry (1990) 1.40
Skeletal applications of videofluoroscopy. J Manipulative Physiol Ther (1990) 1.40
SAPPHIRE: scenarios, architecture, and process. Comput Methods Programs Biomed (1994) 1.39
Tiguvon spot-on and flea control in dogs and cats. Vet Rec (1997) 1.39
Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet Rec (1995) 1.39
Endoscopic retrograde cholangiopancreatography in the investigation and management of patients after acute pancreatitis. Br J Surg (1982) 1.38
Rowachol--a possible treatment for cholesterol gallstones. Gut (1979) 1.37
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37
Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society. Br J Ophthalmol (2002) 1.35
Long-term retrograde amnesia...the crucial role of the hippocampus. Neuropsychologia (2001) 1.31
First clinical results with a real time, electronic imager as an aid to colonoscopy. Gut (1995) 1.31
Auranofin. Br J Rheumatol (1997) 1.30
Intraductal infusion of mono-octanoin: experience in 24 patients with retained common-duct stones. Lancet (1981) 1.30
Nutrition transition in the United Arab Emirates. Eur J Clin Nutr (2011) 1.29
Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet (1998) 1.29
The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol (2000) 1.28
Measurement of exhaled chlorofluorocarbons. Lancet (1988) 1.27
Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study. Br J Clin Pharmacol (1984) 1.26
Lithogenic bile in patients with ileal dysfunction. Gut (1972) 1.26
Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol (1987) 1.26
The [14C]-aminopyrine breath test. A comparison of different forms of analysis. Br J Clin Pharmacol (1979) 1.26
"Eradication" of Campylobacter pylori: are we being misled? Lancet (1988) 1.26
Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry (2001) 1.25
A comparison of winged steel needles and Teflon cannulas in maintaining intravenous access during gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.23
High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest (1985) 1.23
Non-radiological technique for three-dimensional imaging of endoscopes. Lancet (1993) 1.20
Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation. Br Med J (Clin Res Ed) (1984) 1.19